JPH0469632B2 - - Google Patents

Info

Publication number
JPH0469632B2
JPH0469632B2 JP59252425A JP25242584A JPH0469632B2 JP H0469632 B2 JPH0469632 B2 JP H0469632B2 JP 59252425 A JP59252425 A JP 59252425A JP 25242584 A JP25242584 A JP 25242584A JP H0469632 B2 JPH0469632 B2 JP H0469632B2
Authority
JP
Japan
Prior art keywords
propylberberine
crystals
berberine
chloroform
bromide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59252425A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61130289A (ja
Inventor
Tetsuo Ikegawa
Fumitake Shimada
Sotetsu Cho
Kazuo Uebaba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Priority to JP59252425A priority Critical patent/JPS61130289A/ja
Priority to EP85115000A priority patent/EP0184118B1/en
Priority to DE8585115000T priority patent/DE3564434D1/de
Priority to US06/802,447 priority patent/US4761477A/en
Publication of JPS61130289A publication Critical patent/JPS61130289A/ja
Publication of JPH0469632B2 publication Critical patent/JPH0469632B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59252425A 1984-11-29 1984-11-29 １３−プロピルベルベリンの塩 Granted JPS61130289A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP59252425A JPS61130289A (ja) 1984-11-29 1984-11-29 １３−プロピルベルベリンの塩
EP85115000A EP0184118B1 (en) 1984-11-29 1985-11-26 13-propylberberine salts
DE8585115000T DE3564434D1 (de) 1984-11-29 1985-11-26 13-propylberberine salts
US06/802,447 US4761477A (en) 1984-11-29 1985-11-27 13-propylberberine salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59252425A JPS61130289A (ja) 1984-11-29 1984-11-29 １３−プロピルベルベリンの塩

Publications (2)

Publication Number Publication Date
JPS61130289A JPS61130289A (ja) 1986-06-18
JPH0469632B2 true JPH0469632B2 (enExample) 1992-11-06

Family

ID=17237179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59252425A Granted JPS61130289A (ja) 1984-11-29 1984-11-29 １３−プロピルベルベリンの塩

Country Status (4)

Country Link
US (1) US4761477A (enExample)
EP (1) EP0184118B1 (enExample)
JP (1) JPS61130289A (enExample)
DE (1) DE3564434D1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61130289A (ja) * 1984-11-29 1986-06-18 Ss Pharmaceut Co Ltd １３−プロピルベルベリンの塩
US4994367A (en) * 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
FR2728902B1 (fr) * 1994-12-29 1997-01-31 Synthelabo Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique
NZ334954A (en) * 1996-09-23 2000-08-25 Univ Rutgers Substituted heterocycles as anti-tumor agents
KR100258849B1 (ko) * 1998-04-24 2000-08-01 박원배 약학적으로 유용한 프로토베르베린염 유도체 및프로토베르베린유도체와 이의 염
KR20000021073A (ko) 1998-09-25 2000-04-15 박원배 콜레스테롤 생합성 저해제
KR20000042507A (ko) * 1998-12-21 2000-07-15 박원배 콜레스테롤 생합성 저해효과를 나타내는 디벤조[a,g]퀴놀리지늄 유도체
US6740650B2 (en) 1999-10-29 2004-05-25 Rutgers, The State University Of New Jersey Heterocyclic cytotoxic agents
WO2003041653A2 (en) * 2001-11-14 2003-05-22 Rutgers, The State University Cytotoxic agents
WO2003047505A2 (en) * 2001-11-14 2003-06-12 Rutgers, The State University Topoisomerase poison agents
WO2003041660A2 (en) * 2001-11-14 2003-05-22 Rutgers, The State University Solubilized topoisomerase poisons
EP1453507B1 (en) * 2001-11-14 2009-03-04 Rutgers, The State University Solubilized topoisomerase poison agents
WO2004014918A1 (en) * 2002-08-09 2004-02-19 Rutgers, The State University Nitro and amino substituted topoisomerase agents
WO2004014862A1 (en) * 2002-08-09 2004-02-19 Rutgers, The State University Nitro and amino substituted heterocycles as topoisomerase i targeting agents
US6992089B2 (en) * 2002-08-09 2006-01-31 Rutgers, The University Of New Jersey Nitro and amino substituted topoisomerase agents
EP1562593B1 (en) * 2002-11-12 2014-07-16 Rutgers, The State University of New Jersey Topoisomerase-targeting agents
WO2010102219A1 (en) 2009-03-06 2010-09-10 Rutgers, The State University Of New Jersey Methylenedioxybenzo [i] phenanthridine derivatives used to treat cancer
WO2010127363A1 (en) 2009-05-01 2010-11-04 Rutgers, The State University Of New Jersey Toposiomerase inhibitors
EP3442979A4 (en) 2016-04-04 2019-12-18 Rutgers, the State University of New Jersey topoisomerase poisons

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2208659A1 (en) * 1972-10-19 1974-06-28 Kanebo Ltd 13-Alkyl, alkoxy or allyl berberrubin derivatives - anticancer agents, prepd by demethylation of a 13-subst berberine salt
US3910938A (en) * 1973-01-27 1975-10-07 Kanebo Ltd Berbine derivatives
GB1491358A (en) * 1976-06-04 1977-11-09 Kanebo Ltd Pharmaceutical materials
JPS61130289A (ja) * 1984-11-29 1986-06-18 Ss Pharmaceut Co Ltd １３−プロピルベルベリンの塩

Also Published As

Publication number Publication date
JPS61130289A (ja) 1986-06-18
US4761477A (en) 1988-08-02
EP0184118B1 (en) 1988-08-17
DE3564434D1 (de) 1988-09-22
EP0184118A1 (en) 1986-06-11

Similar Documents

Publication Publication Date Title
JPH0469632B2 (enExample)
US3941772A (en) Azacycloalkane-2,2-diphosphonic acids
US3988443A (en) Azacycloalkane-2,2-diphosphonic acids
JPS63500795A (ja) 新規９―ハロゲンプロスタグランジン及びその製法
HU198906B (en) Process for production of cyclodextrin inclusion compounds of carbocyclin derivatives and medical compositions containing them
PT80976B (en) Process for the preparation of benzimidazole derivatives
EP0119949B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JPS628433B2 (enExample)
IL281761B2 (en) Process for preparing calcium alpha-ketoglutarate
JPS6024103B2 (ja) １ｈ−テトラゾ−ル−１−酢酸又はそのエステルの製造法
GB1575147A (en) N-2-imidazolidylidene-benzeneamine and salts thereof
EP0096279B1 (de) N-(2-Methoxyethyl)-noroxymorphon, dessen Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
EP0036218B1 (en) Salts of the 3-hydroxy quinuclidine esters of a phenoxycarboxylic acid, a process for the preparation thereof, and related pharmaceutical compositions
FI74456B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva cystinderivat.
EP0065200B1 (de) Delta-1-Pyrrolin-thiolactimäther und Verfahren zu ihrer Herstellung
JPS6035346B2 (ja) ６―アミノクロマン誘導体
JPS60152462A (ja) インド−ル酢酸アミド誘導体の製造方法
JPH0378384B2 (enExample)
JPS60260540A (ja) ジフタル酸エステル誘導体及びその製造法，並びにこれを有効成分とする抗潰瘍剤
NL8002073A (nl) Nieuwe 16-methoxy-16-methylprostaglandine e1 derivaten, werkwijze voor het bereiden daarvan en hun gebruik als gastroprotectieve middelen.
JPS6210977B2 (enExample)
JPH07121898B2 (ja) アズレン誘導体、抗脂血剤及びその製法
KR820001989B1 (ko) 프로파길-2-페닐아미노-이미다졸린-(2) 유도체의 제조방법
EP0029527A2 (de) Prostaglandinderivate in der 6-Keto-PGA1-Reihe, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln und ihre Zwischenprodukte
JPS643874B2 (enExample)